-
effectivehealthcare-admin.ahrq.gov/sites/default/files/06_devdelays_autism_potential_high_impact_june_2012.pdf
January 01, 2012 - ............................................................................................... 2
Discussion … separately), and then topics in the same class of a
device, drug, or biologic are aggregated for discussion … Discussion
This priority area has a paucity of leads and innovations, despite intensive scanning for … Background
Methods
Results
Discussion
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1312.pdf
December 01, 2013 - ES-2
Discussion ................................................................................... … separately), and then topics in the same class of a
device, drug, or biologic are aggregated for discussion … See the discussion below.
Priority Area 14: Substance Abuse
Topic High-Impact Potential
1. … *Community-based opioid overdose prevention program (Project
Lazarus)
Moderately high
Discussion … Results and Discussion of Comments
Six experts, with clinical, research, health devices, and health
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/public-reporting-cost-measures_research-protocol.pdf
January 13, 2014 - Discussion with Key Informants
We will discuss with key informants how we plan to identify and synthesize … Field notes will be taken during the key
informants’ discussion calls and representatives from AHRQ … answer
Guiding Question 2, we will use information learned from our targeted literature review
and discussion … This assessment will be informed by findings from the
literature searches and discussion with key informants … Agenda for discussion:
1. Introductions and overview of the project
2.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_disposition-comments.pdf
April 25, 2013 - Discussion None
Conclusion None
Figures None
References None
Appendix None
Source … Discussion The implications of the major findings are clearly stated but the
underlying assumptions … Results excluding those trials are
noted now in the tables and stated in the discussion. … Page 23, line 27:
This discussion focuses on hematologic malignancies. … The discussion was informed by CER results. We
acknowledge uncertainties.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-239-episodic-migraine-comments.pdf
December 29, 2020 - These
limitations were acknowledged in the discussion section of the report. … We have updated the discussion
with the following information:
“Although only studied in one or a
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-227-noninvasive-nonpharm-chronic-pain-comments.pdf
April 16, 2020 - Moving forward, we
recommend that AHRQ consider a discussion of stratification
and treatment matching … We believe that the results and discussion
appropriately describes the strenghts and limitations
of … We believe that the results and discussion
appropriately describes the strenghts and limitations
of … In the discussion,w e
acknowledge that the inclusion of some
interventions would have expanded the … The
discussion acknowledges the heterogeneity of what
was described as usual care across studies.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/breast-biopsy_disposition-comments.pdf
March 11, 2010 - Executive summary Executive summary needs a methods section and a discussion
section
The template … was revised to include Methods and
Discussion sections. … The
discussion needs to focus more on the clinical implications of the
biopsy approaches. … We have a detailed discussion of
the possible impact of the assumption that false-
positives do not … Discussion The future research section should be enlarged.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/omega-3-maternity_disposition-comments.pdf
October 12, 2016 - Yes, we agree and have attempted to
delineate the limitations in the Discussion
chapter, which we have … We have noted this limitation in the
Discussion chapter. … We have now added a discussion of this
point in the Limitations section of the
Discussion. … TEP Reviewer
#3
Discussion/Conclusion Yes No response seems to be needed. … of
supplemental n-3 FA in the Discussion.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/nursing-home-safety_disposition-comments.pdf
May 27, 2016 - This is
fundamental to how we approach any discussion about safety in NHs. … Peer reviewer #5 Findings GQ1c—The discussion on pressure ulcers is insufficient. … They also use the term staffing model but the discussion is
very confusing and unclear. … We have moved this discussion and
made it more clear why we believe it is
important. … The discussion has little to do with nursing homes.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/study-design-framework_research.pdf
March 01, 2012 - Each proposed research design is
accompanied by a discussion of advantages and disadvantages for using … Role of Study Design Considerations Within Future Research
Needs
The EPCs add a short discussion of … The discussion of study design in the
AHRQ FRN documents should be only a first step in developing … The study design terms used in this discussion are listed in Table 1, and descriptions are
provided … Such discussion can be useful, however, in illustrating
some of the challenges inherent to CER.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1506.pdf
November 01, 2016 - ES-2
Discussion ................................................................................... … separately), and then topics in the same class of a
device, drug, or biologic are aggregated for discussion … Results and Discussion of Comments
Six experts, with clinical, research, health systems, and health … Executive Summary
Background
Methods
Results
Discussion
Elagolix for Treatment of Endometriosis … Elagolix for Treatment of Endometriosis
Clinical Pathway at Point of This Intervention
Results and Discussion
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1312.pdf
December 01, 2013 - ES 2
Discussion ................................................................................... … separately), and then topics in the same class of a
device, drug, or biologic are aggregated for discussion … Results and Discussion of Comments
Six experts, with clinical, research, health systems, and health … page=all
Executive Summary
Background
Methods
Results
Discussion
Vending Machine Dispensers for … (Plan B One-Step) To Prevent Pregnancy
Clinical Pathway at Point of This Intervention
Results and Discussion
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1512.pdf
November 01, 2016 - ES-2
Discussion ................................................................................... … separately), and then topics in the same class of a
device, drug, or biologic are aggregated for discussion … Elagolix for treatment of endometriosis Lower end of the high-impact-potential range
Discussion
We … Results and Discussion of Comments
Six experts, with clinical, research, health systems, and health … Elagolix for Treatment of Endometriosis
Clinical Pathway at Point of This Intervention
Results and Discussion
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1306.pdf
June 01, 2013 - ES-2
Discussion ................................................................................... … separately), and then topics in the same class of a
device, drug, or biologic are aggregated for discussion … Results and Discussion of Comments
Six experts, with clinical, research, and health systems backgrounds … , provided comments on this
topics.16-21 We organized the following discussion of expert comments according … Executive Summary
Background
Methods
Results
Discussion
Off-Label Intranasal Oxytocin (Syntocin)
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1306.pdf
June 11, 2013 - ES-2
Discussion ................................................................................... … separately), and then topics in the same class of a
device, drug, or biologic are aggregated for discussion … Results and Discussion of Comments
Six experts, with clinical, research, health systems, and health … page=all
Executive Summary
Background
Methods
Results
Discussion
Vending Machine Dispensers for … (Plan B One-Step) To Prevent Pregnancy
Clinical Pathway at Point of This Intervention
Results and Discussion
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_disposition-comments.pdf
April 01, 2012 - Additional text was added to KQ4a to point
to this section for discussion of the OHTS. … Please add a discussion of the applicability of the
reviewed studies to the discussion of each key question … Text to this effect has been added to the discussion of
KQ3b. … We have added some text to the
discussion of KQ3b to address the AGIS. … Peer Reviewer
#3
Discussion The discussion discounted the patient-reported outcome of
reduced fear
-
effectivehealthcare-admin.ahrq.gov/products/deliberative-methods/research-2013
January 01, 2019 - The process includes educational and discussion-based components (i.e., the “information phase” and the … Public deliberation is designed to allow discussion and negotiation concerning complex social issues. … Discussion of approaches to record and summarize deliberative dialogue is very limited in the literature … , as is the discussion of approaches to reporting the results of deliberative activities to the sponsor … The literature presents a comprehensive discussion of the principles of public deliberation, the goals
-
effectivehealthcare-admin.ahrq.gov/products/pelvic-pain/research-protocol
December 01, 2020 - After discussion with our TEP following the public posting of the key questions, we further refined the … We also corrected a misalignment between our discussion of outcome measures and our requirement of the … We will note in our discussion of these studies that the results apply to the whole population and should … We will note in our discussion of these studies that the results apply to the whole study population … When extracting data on female subjects only is not possible, we will note in our discussion of these
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/cf_deliberativemethodswebinar_goalsetting.pdf
May 18, 2012 - topic &
questions
• Build facilitation
capacity
• Connect to decision
makers
• Plan events
• Discussion
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/use_of_handheld_osheroff_respondent.pdf
January 01, 2009 - [discussion]
Slide
3:
Handheld
+
4
Other
CDS
Rights
• What
types